StreetInsider.com News Articles

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec (LSE:CTEC), a leading medical products and technologies company focused on solutions for the management of chronic conditions; The Eli Lilly and Company Foundation (Lilly Foundation), a tax-exempt private foundation supported by donations from Eli Lilly and Company (NYSE:LLY) have committed c.$5 million to Partners In Health (PIH), an international nonprofit global health organization to help accelerate the integration of non‑communicable disease (NCD) and chronic care, including cardiometabolic and mental health, into primary and community health systems in resource-limited settings.

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene
Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes
Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from

Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 2026

Tue, 05 May 2026 10:11:00 -0400

Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound Hygiene

Convatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomes

Convatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year

LONDON--(BUSINESS WIRE)-- Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from